← Back to Search

Brain Stimulation + Cognitive Training for Anorexia

Phase 1

Recruiting

Led By Lisa Anderson

Research Sponsored by University of Minnesota

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 18-65 years

Be older than 18 years old

Must not have

Serious psychiatric disorder known to affect brain functioning and cognitive performance (e.g., schizophrenia, schizoaffective disorder)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 14 days average

Summary

"This trial is studying adults with restrictive eating disorders who are getting outpatient treatment to see if a new brain stimulation technique called transcranial direct current stimulation (tDCS) can improve brain training. Participants

Who is the study for?

Adults with restrictive eating disorders like Anorexia Nervosa, who are currently in outpatient treatment. Participants will undergo interviews and assessments. They must be available for 10 sessions over 3-4 weeks plus follow-up visits.

What is being tested?

The study tests if brain stimulation using a StarStim device can improve the effectiveness of computerized brain training. Participants receive either real (active) tDCS or fake (sham) sessions to compare outcomes.

What are the potential side effects?

tDCS is generally well-tolerated but may cause mild side effects such as itching, tingling, or discomfort at the electrode site; headache; fatigue; and nausea.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 65 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I do not have a psychiatric disorder affecting my thinking.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 14 days average

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~14 days average

This trial's timeline: 3 weeks for screening, Varies for treatment, and 14 days average for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Dimensional set shifting task

Number of participants retained in the tDCS

probabilistic reversal learning task

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Active tDCSExperimental Treatment1 Intervention

10 Active tDCS sessions: 10 active sessions of transcranial direct current stimulation paired with cognitive training tasks. Device used is StarStim.

Group II: Sham (fake) tDCSPlacebo Group1 Intervention

10 Sham (fake) tDCS sessions: 10 fake sessions of transcranial direct current stimulation paired with cognitive training tasks. The device will be on the participants head, but the current will not be active.

0 / 2Eligibility criteria met